tanios bekaii-saab, md: clinical data supporting regorafenib in mcrc
Published 8 years ago • 152 plays • Length 1:20
Download video MP4
Download video MP3
Similar videos
-
1:12
tanios bekaii-saab, md: mechanisms of action in regorafenib
-
0:28
tanios bekaii-saab, md: reinitiating regorafenib in patients with mcrc
-
1:40
tanios bekaii-saab, md: clinical data supporting trifluradine-tipiracil
-
0:51
tara seery, md: clinical data supporting regorafenib in mcrc
-
1:40:18
colorectal cancer
-
54:38
detecting circulating tumor cells - dr. daniel sabath
-
5:19
stivarga moa. austin visuals
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
1:45
tanios bekaii-saab, md: main adverse events with regorafenib
-
1:21
tanios bekaii-saab, md: regorafenib dose adjustments
-
1:20
dr. bekaii-saab on the use of regorafenib in patients with mcrc
-
1:27
tanios bekaii-saab, md, comments on dosing regorafenib (stivarga) in 3rd line treatment of mcrc
-
1:21
dr. bekaii-saab discusses regorafenib use in mcrc
-
2:17
tanios bekaii-saab, md: first-line treatments in unresectable colon cancer
-
1:39
dr. bekaii-saab on dosing strategies with regorafenib in crc
-
2:19
tanios bekali-saab, md, on utilizing regorafenib (stivarga) and trifluridine (lonserf)
-
2:02
tanios bekaii-saab, md: impact of third-line therapy
-
2:22
dr. tanios bekaii-saab on new agents to treat colorectal cancer
-
2:56
tanios bekaii saab, md: treatment toxicities and quality of life
-
0:26
tanios bekaii-saab, md: ras mutations in metastatic colorectal cancer
-
4:32
tanios bekaii-saab, md: cost issues with ct regimens and bevacizumab
-
6:49
achieving a durable response with regorafenib in mcrc
Clip.africa.com - Privacy-policy